These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 2568682
21. Vasodilator responses to dopamine in rat perfused mesentery are age-dependent. Wanstall JC, O'Donnell SR. Br J Pharmacol; 1989 Sep; 98(1):302-8. PubMed ID: 2804550 [Abstract] [Full Text] [Related]
22. Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles. Zeng C, Wang D, Yang Z, Wang Z, Asico LD, Wilcox CS, Eisner GM, Welch WJ, Felder RA, Jose PA. Hypertension; 2004 Mar; 43(3):673-9. PubMed ID: 14769810 [Abstract] [Full Text] [Related]
23. Anatomical localization of the binding and functional characterization of responses to dopexamine hydrochloride in the rat mesenteric vasculature. Amenta F, Ricci A, Napoleone P, Vyas SJ, Lokhandwala MF. Pharmacology; 1991 Mar; 42(4):211-22. PubMed ID: 1677201 [Abstract] [Full Text] [Related]
32. The action of dopamine and vascular dopamine (DA1) receptor agonists on human isolated subcutaneous and omental small arteries. Hughes AD, Sever PS. Br J Pharmacol; 1989 Jul; 97(3):950-6. PubMed ID: 2474354 [Abstract] [Full Text] [Related]
33. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung. Polak MJ, Taylor DA. Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367 [Abstract] [Full Text] [Related]
34. Systemic and pulmonary vascular effects of selective dopamine receptor blockade and stimulation in lambs. Polak MJ, Drummond WH. Pediatr Res; 1993 Feb; 33(2):181-4. PubMed ID: 8094550 [Abstract] [Full Text] [Related]
35. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog. Kopia GA, Valocik RE. J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287 [Abstract] [Full Text] [Related]
37. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat. Le Monnier de Gouville AC, Lawson K, Thiry C, Cavero I. J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375 [Abstract] [Full Text] [Related]
38. [Effects of l-stepholidine on the peripheral vascular dopamine DA1 and DA2 receptor subtypes]. Zhang W, Zhi J, Guo W, Zhao R, Jin G. Yao Xue Xue Bao; 1998 Oct; 33(10):721-6. PubMed ID: 12016922 [Abstract] [Full Text] [Related]
39. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow. Zhao RR, Wang PH, Zhang WF, Fennell WH. Methods Find Exp Clin Pharmacol; 1992 Oct; 14(1):5-11. PubMed ID: 1352371 [Abstract] [Full Text] [Related]
40. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. Hahn RA, Wardell JR, Sarau HM, Ridley PT. J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]